COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
Today Spectranetics is positioned to continue growth in both the Vascular Intervention, Lead Management business in the Unites States and Internationally. The company has a robust product pipeline and ...
The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...
The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (“Company”) (Nasdaq:SPNC) today reported the settlement of matters related to the federal investigation initiated by the Food & Drug ...
ORLANDO, Florida — Transvenous extraction of unused pacemaker or defibrillator leads poses a higher risk for death as an acute complication when it's performed by using a laser-based extraction sheath ...
Please provide your email address to receive an email when new articles are posted on . A recent recall of a bridge occlusion catheter has been classified as class I, the most serious kind, due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results